S 920 — National Clinical Care Commission Act
Last action — Became Public Law No: 115-80.
-
✓Introduced
-
✓In Committee
-
✓Passed Senate
-
✓Passed House
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced April 24, 2017. Enacted.
Prognosis
Where this bill stands today.
Odds of enactment
HighHow often bills like it became law.
-
Enacted
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 D).
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
Bill Text
What changed in the latest version
51 added · 55 removedPlain-language change summary
The amendment adds language specifying that the National Clinical Care Commission will include twelve additional voting members with expertise in the prevention, care, and epidemiology of relevant diseases and complications. This change clarifies the composition of the Commission and ensures a broad range of expertise is represented. The amendment highlights the importance of including diverse perspectives in addressing the disease burden in the United States.
[Congressional[115th BillsCongress 115thPublic Congress]Law 80] [From the U.S.
Government Publishing Office] [S.[[Page 131 STAT.
9201261]] EngrossedPublic inLaw Senate115-80 (ES)]115th <DOC>Congress 115thAn CONGRESSAct 1stTo Sessionestablish S.a National Clinical Care Commission.
920<<NOTE: _______________________________________________________________________ AN ACT To establish a National Clinical Care Commission.
BeNov. it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1.
2, - [S.
920]>> Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, <<NOTE:
National Clinical Care Commission Act.>> SECTION 1.
NATIONAL<<NOTE: CLINICAL CARE COMMISSION.
Evaluation.
Recommenda- tions.>> NATIONAL CLINICAL CARE COMMISSION.
(2) Additional members.--The Commission shall include additional voting members, as may be appointed by the Secretary, with expertise in the prevention, care, and epidemiology of any of the diseases and complications described in subsection (a),[[Page including131 oneSTAT. or more such members from each of the following categories:
1262]] (a), including one or more such members from each of the following categories:
(d) Operating<<NOTE: Plan.--Not later than 90 days after its first meeting, the Commission shall submit to the Secretary of Health and Human Services and the Congress an operating plan for carrying out the activities of the Commission as described in subsection (c).
SuchDeadline.>> operatingOperating planPlan.--Not maylater include--than (1)90 adays listafter ofits specificfirst activitiesmeeting, that the Commission plansshall submit to conductthe forSecretary purposes of carryingHealth outand Human Services and the dutiesCongress describedan inoperating eachplan for carrying out the activities of the paragraphsCommission as described in subsection (c);(c).
Such operating plan may include-- [[Page 131 STAT.
1263]] (1) a list of specific activities that the Commission plans to conduct for purposes of carrying out the duties described in each of the paragraphs in subsection (c);
PassedApproved theNovember Senate2, September 6, 2017.
Attest:LEGISLATIVE HISTORY--S.
Secretary.920:
115th--------------------------------------------------------------------------- CONGRESSCONGRESSIONAL 1stRECORD, SessionVol. S.
920163 _______________________________________________________________________(2017): AN ACT To establish a National Clinical Care Commission.
Sept.
6, considered and passed Senate.
Oct.
11, considered and passed House.
<all>
View plain text versions (5)
- Chaptered Public Law Current html November 02, 2017
- Engrossed Engrossed in Senate html September 06, 2017
- Reported Reported to Senate html May 01, 2017
- Introduced Introduced in Senate html April 24, 2017
- Enrolled Enrolled Bill html
Action History
-
Introduced in Senate
-
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
-
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.
-
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.
-
Placed on Senate Legislative Calendar under General Orders. Calendar No. 47.
-
Measure laid before Senate by unanimous consent. (consideration: CR S5019-5020)
-
Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.(text: CR S5019-5020)
-
Passed Senate with amendments by Unanimous Consent. (text: CR S5019-5020)
-
Message on Senate action sent to the House.
-
Received in the House.
-
Held at the desk.
-
Mr. Olson moved to suspend the rules and pass the bill.
-
Considered under suspension of the rules. (consideration: CR H7946-7948)
-
DEBATE - The House proceeded with forty minutes of debate on S. 920.
-
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H7946)
-
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7946)
-
Motion to reconsider laid on the table Agreed to without objection.
-
Presented to President.
-
Presented to President.
-
Signed by President.
-
Signed by President.
-
Became Public Law No: 115-80.
-
Became Public Law No: 115-80.
Sponsors
- Jeanne Shaheen · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
- Shaheen, Jeanne Democratic
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S 920 do?
- (This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
- Who sponsors S 920?
- S 920 is sponsored by Shaheen, Jeanne (Democratic).
- What is the current status of S 920?
- This bill has been enacted into law. Introduced April 24, 2017. Enacted.
- Where can I track S 920?
- Track S 920 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S 920
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S 920
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →